Costa Rica vs Estonia: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Costa Rica
- Estonia
How they compare
Costa Rica currently reports 1,074 Cases against 9 Cases in Estonia, a difference of 1,065 Cases.
That makes Costa Rica's figure about 119.3 times Estonia's.
Across all 32 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 8th and Estonia ranks 7th of 34 countries.
Costa Rica has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Costa Rica | Estonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 202.86 Cases | 3.14 Cases | 199.71 Cases | Costa Rica |
| 2000s | 259.7 Cases | 26.6 Cases | 233.1 Cases | Costa Rica |
| 2010s | 834.9 Cases | 27.7 Cases | 807.2 Cases | Costa Rica |
| 2020s | 874.2 Cases | 13.4 Cases | 860.8 Cases | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Costa Rica or Estonia?
- Costa Rica, at 1,074 Cases against 9 Cases in Estonia as of 2025.
- What is the difference in communicable diseases — communicable disease incidence between Costa Rica and Estonia?
- 1,065 Cases, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Estonia?
- 32 years are reported by both, from 1993 to 2024.
- How do Costa Rica and Estonia rank globally for communicable diseases — communicable disease incidence?
- Costa Rica ranks 8th and Estonia ranks 7th of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.